[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"menu":3,"$ftH2dzLhvNj7-lJqfFiHVKMmMRYCKyRuXTIj8zjaerYk":210},{"main":4,"mainTranslated":17,"footer":45,"footerTranslated":109},[5,8,11,14],{"title":6,"url":7},"Course library","https:\u002F\u002Fwww.medmastery.com\u002Fcourse-library",{"title":9,"url":10},"Pricing","https:\u002F\u002Fwww.medmastery.com\u002Fpricing",{"title":12,"url":13},"Earn credits","https:\u002F\u002Fwww.medmastery.com\u002Fcme-credits",{"title":15,"url":16},"Institutions","https:\u002F\u002Fwww.medmastery.com\u002Finstitutions",{"de":18,"es":27,"fr":36},[19,21,23,25],{"title":20,"url":7},"Kurse",{"title":22,"url":10},"Preise",{"title":24,"url":13},"CME-Punkte",{"title":26,"url":16},"Organisationen",[28,30,32,34],{"title":29,"url":7},"Biblioteca de cursos",{"title":31,"url":10},"Precios",{"title":33,"url":13},"Gana créditos",{"title":35,"url":16},"Instituciones",[37,39,41,43],{"title":38,"url":7},"Cours",{"title":40,"url":10},"Tarifs",{"title":42,"url":13},"Obtenir des crédits",{"title":44,"url":16},"Établissements",[46,59,79,97],{"title":47,"group":48,"menu":49},"Company",true,[50,53,56],{"title":51,"url":52},"Our teachers","https:\u002F\u002Fwww.medmastery.com\u002Fteachers",{"title":54,"url":55},"About us","https:\u002F\u002Fwww.medmastery.com\u002Fabout-us",{"title":57,"url":58},"Work with us","https:\u002F\u002Fwww.medmastery.com\u002Fwork-with-us",{"title":60,"group":48,"menu":61},"Product",[62,64,67,70,73,76,78],{"title":63,"url":7},"Courses",{"title":65,"url":66},"Magazine","https:\u002F\u002Fwww.medmastery.com\u002Fmagazine",{"title":68,"url":69},"Podcast","https:\u002F\u002Fwww.medmastery.com\u002Fpodcasts",{"title":71,"url":72},"Webinars","https:\u002F\u002Fwww.medmastery.com\u002Fwebinars",{"title":74,"url":75},"Guides","https:\u002F\u002Fwww.medmastery.com\u002Fguides",{"title":15,"url":77},"https:\u002F\u002Fwww.medmastery.com\u002Finstitutions\u002F",{"title":9,"url":10},{"title":80,"group":48,"menu":81},"Legal",[82,85,88,91,94],{"title":83,"url":84},"Imprint","https:\u002F\u002Fwww.medmastery.com\u002Fimprint",{"title":86,"url":87},"Newsletter policy","https:\u002F\u002Fwww.medmastery.com\u002Fnewsletter-privacy-policy",{"title":89,"url":90},"Privacy policy","https:\u002F\u002Fwww.medmastery.com\u002Fprivacy-policy",{"title":92,"url":93},"Cookie Policy","https:\u002F\u002Fwww.medmastery.com\u002Fcookie-policy",{"title":95,"url":96},"Terms","https:\u002F\u002Fwww.medmastery.com\u002Fterms",{"title":98,"group":48,"menu":99},"Customer support",[100,103,106],{"title":101,"url":102},"FAQs","https:\u002F\u002Fwww.medmastery.com\u002Ffaqs",{"title":104,"url":105},"Contact","https:\u002F\u002Fwww.medmastery.com\u002Fcontact",{"title":107,"url":108},"support@medmastery.com","mailto:support@medmastery.com",{"de":110,"es":143,"fr":177},[111,118,128,137],{"title":112,"group":48,"menu":113},"Unternehmen",[114,116,117],{"title":115,"url":52},"Unsere Dozentinnen und Dozenten",{"title":54,"url":55},{"title":57,"url":58},{"title":119,"group":48,"menu":120},"Produkt",[121,122,123,124,125,126,127],{"title":20,"url":7},{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":26,"url":77},{"title":22,"url":10},{"title":129,"group":48,"menu":130},"Rechtliches",[131,133,134,135,136],{"title":132,"url":84},"Impressum",{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":138,"group":48,"menu":139},"Kundenservice",[140,141,142],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},[144,151,162,171],{"title":145,"group":48,"menu":146},"Empresa",[147,149,150],{"title":148,"url":52},"Nuestros profesores",{"title":54,"url":55},{"title":57,"url":58},{"title":152,"group":48,"menu":153},"Producto",[154,156,157,158,159,160,161],{"title":155,"url":7},"Cursos",{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":35,"url":77},{"title":31,"url":10},{"title":163,"group":48,"menu":164},"Información legal",[165,167,168,169,170],{"title":166,"url":84},"Aviso legal",{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":172,"group":48,"menu":173},"Atención al cliente",[174,175,176],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},[178,185,196,204],{"title":179,"group":48,"menu":180},"Entreprise",[181,183,184],{"title":182,"url":52},"Nos enseignants",{"title":54,"url":55},{"title":57,"url":58},{"title":186,"group":48,"menu":187},"Produit",[188,189,190,191,192,193,194],{"title":38,"url":7},{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":15,"url":77},{"title":195,"url":10},"Tarification",{"title":197,"group":48,"menu":198},"Mentions légales",[199,200,201,202,203],{"title":197,"url":84},{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":205,"group":48,"menu":206},"Service client",[207,208,209],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},{"content":211,"related":300,"meta":366,"internal":378},{"title":212,"leadIn":213,"category":214,"elements":217,"becomeAnExpert":247,"author":286,"readDuration":298,"readDurationFormatted":299},"Starting statins as first-line therapy: selection and monitoring","Statins are first-line therapy for hyperlipidemia—but how do you approach starting statins in your patient? This lesson covers statin intensity, agent selection, and monitoring after initiation, so you can align treatment with your patient’s cardiovascular risk.",{"id":215,"name":216},1,"Course previews",[218,229,234,242],{"type":219,"data":220},"video",{"readDurationInSeconds":221,"video":222},368,{"platform":223,"name":224,"url":225,"size":226},"YouTube","Prescribing Statins: What and When | Hyperlipidemia Management and Reducing Cardiovascular Risk","https:\u002F\u002Fyoutu.be\u002FY0AE-JoZnmU",{"width":227,"height":228},200,113,{"type":230,"data":231},"free_text",{"readDurationInSeconds":232,"text":233},27.733333333333334,"\u003Cp>Starting statins as first-line therapy depends on your patient’s LDL-C, cardiovascular risk, and other clinical factors. This lesson outlines how to choose statin intensity, monitor after initiation, and address side effects and common concerns about memory loss and diabetes risk—so you can prescribe statins with clarity.\u003C\u002Fp>\u003Cp>In this lesson from our \u003Ca href=\"https:\u002F\u002Fwww.medmastery.com\u002Fcourses\u002Fhyperlipidemia-essentials\">Hyperlipidemia Essentials\u003C\u002Fa> course, you will learn how to:\u003C\u002Fp>\u003Cul>\u003Cli data-list-item-id=\"e6167d0a9784f356de9e1404cf3b8e3ce\">Explain how statins reduce LDL and improve the broader lipid profile\u003C\u002Fli>\u003Cli data-list-item-id=\"e56b6005b42dd55acc95e54951343c6d3\">Classify statin therapy by intensity and match it to your patient's cardiovascular risk\u003C\u002Fli>\u003Cli data-list-item-id=\"e4faf55c9e23fe03fd0e924a0bc67e78c\">Choose a statin based on potency, side effect profile, and drug interaction risk\u003C\u002Fli>\u003Cli data-list-item-id=\"e2f6fdc22cc763f181c4883c2f7a069d2\">Recognize the most common side effect and identify risk factors\u003C\u002Fli>\u003Cli data-list-item-id=\"eef8931c5a5cbd3889a3063c7dbcb80e7\">Address common patient concerns \u003C\u002Fli>\u003Cli data-list-item-id=\"e0cecc1d142921cd2dd674ba62b9e7ed0\">Monitor statins effectively after initiation\u003Cbr> \u003C\u002Fli>\u003C\u002Ful>",{"type":235,"data":236},"cta",{"readDurationInSeconds":237,"text":238,"buttonText":239,"buttonUrl":240,"teachIllustration":241},3.466666666666667,"Start the first chapter of our Hyperlipidemia Essentials course for free","Start chapter 1 now","https:\u002F\u002Fwww.medmastery.com\u002Fuser\u002Fregister?target=%2Fcourses%2Fhyperlipidemia-essentials","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9e69bd56-6248-483e-a304-3f73132e69ee",{"type":230,"data":243},{"readDurationInSeconds":244,"title":245,"text":246},194.4,"Transcript","\u003Ch3 dir=\"ltr\" id=\"docs-internal-guid-20dde5b4-7fff-2b8d-bad6-b586a462690e\">\u003Cspan>How statins inhibit cholesterol synthesis in the liver\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[0:00]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Statins are the go to treatment for managing high cholesterol, lowering LDL levels, and reducing the risk of heart attacks, strokes, and other cardiovascular events. These medications work by blocking the binding of HMG-CoA to HMG-CoA reductase in the liver. Uninhibited, this enzyme drives the reaction that determines how quickly cholesterol is made. When a statin inhibits this enzyme, less cholesterol is produced. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>How statins lower circulating LDL cholesterol particles\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[0:33]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Now the liver, in an effort to compensate for the now lowered levels of cholesterol, increases its production of the LDL receptor, which then binds to the LDL cholesterol particles in the blood and removes them from the bloodstream, effectively lowering blood LDL levels.The liver also decreases VLDL production, reducing triglycerides and increasing HDL. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Statin intensity and LDL cholesterol reduction\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[1:04]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Statin therapy is categorized based on how much it lowers LDL cholesterol. High intensity statin therapy can lower LDL by 50% or more. Moderate intensity statins lower LDL by 30 to 49%, and low intensity statins lower LDL by less than 30%.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>High intensity statins: when to use them\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[1:26]\u003C\u002Fspan>\u003Cbr>\u003Cspan>High intensity statins like atorvastatin and rosuvastatin are prescribed to patients with clinical CVD [cardiovascular disease], those with high LDL levels, and high risk diabetes patients. But they can also be prescribed as moderate intensity therapy at lower doses.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Moderate and low intensity statins in practice\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[1:44]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Statins like simvastatin, pravastatin, and fluvastatin are used most often in moderate intensity therapy for patients who can't tolerate high intensity therapy or have lower cardiovascular risk, including patients living with diabetes. At lower doses, these statins can also be used in low intensity statin therapy for patients with the lowest risk of CVD.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Common statin side effects\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[2:10]\u003C\u002Fspan>\u003Cbr>\u003Cspan>The most common side effect of statins is myalgia, or muscle pain, which affects between 5% and 10% of patients. These symptoms are usually mild and may be influenced by the nocebo effect, where negative expectations about the medication contribute to perceived side effects.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Rare but serious side effect of statin drugs\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[2:28]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Rarely, statins can cause rhabdomyolysis, a severe condition where muscle cells break down, leading to muscle pain, weakness, and potential kidney damage. This serious side effect is more common in older adults, dehydrated individuals, those who are immunocompromised, or patients taking fibrates or other medications that interact with statins.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Muscle-related statin side effects beyond myalgia\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[2:53]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Other muscle-related side effects include myopathy and myositis, otherwise known as inflammation of the muscle. However, the incidence and severity of these effects can vary among the different statin therapy intensities and medications.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Why hydrophilic statins have fewer side effects\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[3:09]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Hydrophilic statins like pravastatin, rosuvastatin, and fluvastatin tend to have fewer side effects because they're less permeable and stay in the bloodstream until they reach the liver. Pravastatin, while less potent, is often preferred for its minimal muscle-related side effects and lower risk of drug interactions.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Statin myths: memory loss and cognitive function\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[3:23]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Now let's debunk some statin myths. Myth number one is that statins cause memory loss. In 2012, a series of flawed studies linked memory loss to statin use and the United States Food and Drug Administration, or FDA, required statin drug labels to include information about memory loss and cognitive function. Many people worried that lower cholesterol levels might impair brain function, but the brain produces its own cholesterol and does not rely on the cholesterol present in the blood. The studies were poorly designed, lacking many scientific controls needed for validity, and often relying on anecdotal evidence and self reported symptoms.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Evidence on cognitive safety with statins\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[4:15]\u003C\u002Fspan>\u003Cbr>\u003Cspan>To confirm this association, additional well-designed studies were performed, including large scale, randomized, controlled trials and observational studies, but no significant difference in cognitive function between statin users and non-users was ever found. The FDA has since clarified that the potential cognitive effects are rare and reversible when they do occur, and the benefits of statins in reducing cardiovascular events far outweighs the risks.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Statin myths: risk of diabetes\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[4:45]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Myth number two is that statins increase the risk of diabetes. While statins can slightly raise blood sugar levels, this is mainly a concern for patients with existing pre-diabetes. For these individuals, a diabetes diagnosis might just confirm a pre-existing condition. Importantly, the cardiovascular benefits of statins far outweigh this slight risk, especially for high risk patients.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Monitoring lipid levels after starting statins\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[5:10]\u003C\u002Fspan>\u003Cbr>\u003Cspan>Once someone begins or adjusts statin therapy, it's important to check lipid levels within 4 to 12 weeks, and once stable, you should recheck the patient's lipid levels every 3 to 12 months. This allows you to assess how much LDL has been lowered and to check patients' adherence to the medication. Routine liver function tests aren't necessary unless there are symptoms of liver toxicity. Even elevated liver enzymes up to three times the normal limit are usually safe, given that statins work on liver cells.\u003C\u002Fspan>\u003C\u002Fp>",{"courses":248,"showAwardsBelow":48},[249,268],{"id":250,"isFreeCmeCourse":251,"title":252,"type":253,"specialization":254,"teachers":256,"cmeCredits":215,"teacherIllustration":258,"backgroundImage":259,"relativeUrl":260,"lastChanged":261,"created":262,"description":263,"relativeURL":260,"meta":264},10336,false,"Hypertension Mini","course",[255],"Cardiology",[257],"Franz Wiesbauer, MD MPH","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55ea4-0fcd-4aee-a883-e80d1132ae0c","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55ea4-eeb8-4aef-b9ad-40de0ee8e824","\u002Fcourses\u002Fhypertension-mini","1763556347","1647215867","With so many antihypertensive agents to choose from, determining which medications to use can be daunting. In this course, we’ll break down the most recent hypertension guidelines and tell you when to use (or not to use) the top four, first-line agents. This will help you to quickly and effectively make treatment decisions for the majority of your patients.",{"duration":265,"quizzes":266,"lessons":267},2314,2,13,{"id":269,"isFreeCmeCourse":251,"title":270,"type":253,"specialization":271,"teachers":273,"cmeCredits":275,"teacherIllustration":276,"backgroundImage":277,"relativeUrl":278,"lastChanged":279,"created":280,"description":281,"relativeURL":278,"meta":282},14079,"Diabetes Mellitus Essentials",[272],"Endocrinology",[274],"Tracy Tylee, MD",5.5,"https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9fe1dd99-6a02-4702-9c27-0af1632a7380","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9fe1de7d-ba19-4358-9a24-277934d51c18","\u002Fcourses\u002Fdiabetes-mellitus-essentials","1769265890","1757924606","Confidently manage diabetes from day one! This course gives you the fundamental skills to assess, treat, and monitor patients with diabetes safely and effectively. You’ll learn how to select appropriate therapies, start and adjust insulin regimens, and use blood glucose readings to guide dosing. The course also covers screening for complications, interpreting lab values, and applying strategies to prevent disease progression. By the end, you’ll be able to deliver patient-centered care that supports improved glycemic control and long-term health outcomes.",{"duration":283,"quizzes":284,"lessons":285},11342,11,50,{"id":287,"name":257,"image":288,"profession":289,"relativeUrl":292,"specializations":293},1563,"https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9c43cef0-41ee-4005-9e4a-d8711c816401",{"name":290,"description":291},"Internist","Franz is the founder and CEO of Medmastery. He is an internist with a specialization in cardiology and a master’s in public health from Johns Hopkins University.","\u002Fteachers\u002Ffranz-wiesbauer-md-mph",[294,295,255,296,297],"Nephrology","Professional development","Ultrasound","Emergency medicine and critical care",238,"4m",[301,323,342],{"id":302,"title":303,"text":304,"image":305,"author":313,"path":316,"readDuration":317,"readDurationFormatted":318,"internal":319},1350,"How to recognize INOCA (ANOCA) on an exercise stress test ","Angina, abnormal stress test, clean coronaries—that's INOCA (or ANOCA), and it carries real risk. Learn to recognize and report it with exercise stress ECG.",{"alt":306,"title":307,"size":308,"location":310},"Illustration of the heart's coronary vasculature showing large coronary arteries and the extensive network of smaller vessels affected in INOCA (ischemia with nonobstructive coronary arteries).","",{"width":309,"height":309},1200,{"bucket":311,"key":312},"public-drupal-medmastery-assets-production","\u002F2026-05\u002FC17(1)_magazine image_0.png",{"id":287,"title":257,"relativeURL":292,"image":288,"professionLong":291,"profession":314,"weight":315},{"name":290},4,"\u002Fmagazine\u002Fexercise-stress-ecg-inoca",141,"3m",{"created":320,"updated":321,"published":322},1778115738,1778799792,1778118255,{"id":324,"title":325,"text":326,"image":327,"author":333,"path":335,"readDuration":336,"readDurationFormatted":337,"internal":338},1348,"Hyperlipidemia screening: who, when, & what to measure","Testing for hyperlipidemia can help you mitigate your patients' cardiovascular risk. Learn who to screen and when, which measures to request, and how to stratify risk.",{"alt":328,"title":307,"size":329,"location":331},"Lipid panel blood sample tubes used to test for hyperlipidemia in a laboratory setting",{"width":330,"height":330},600,{"bucket":311,"key":332},"\u002F2026-04\u002FC121_magazine image.png",{"id":287,"title":257,"relativeURL":292,"image":288,"professionLong":291,"profession":334,"weight":315},{"name":290},"\u002Fmagazine\u002Ftest-for-hyperlipidemia",246,"5m",{"created":339,"updated":340,"published":341},1777403036,1777572381,1777412421,{"id":343,"title":344,"text":345,"image":346,"author":351,"path":360,"readDuration":361,"readDurationFormatted":299,"internal":362},1347,"Outpatient care for COPD exacerbations","Most acute COPD exacerbations can be managed with outpatient treatment. Learn how to treat mild and moderate COPD exacerbations—and when to escalate care.",{"alt":347,"title":307,"size":348,"location":349},"Older patient using a handheld nebulizer to inhale bronchodilator medication during an acute COPD exacerbation",{"width":330,"height":330},{"bucket":311,"key":350},"\u002F2026-04\u002FC133(4)_ exacerbations_magazine image.png",{"id":352,"title":353,"relativeURL":354,"image":355,"professionLong":356,"profession":357,"weight":359},5365,"Siamak Moayedi, MD","\u002Fteachers\u002Fsiamak-moayedi-md","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9c43cf02-1064-4074-817b-0eb5de6ded74","Professor and Director of Medical Student Education, University of Maryland and Course Director, Essential and Critical Procedures, Emergency Medicine.",{"name":358},"Emergency medicine physician",1533,"\u002Fmagazine\u002Facute-copd-exacerbation-treatment",191,{"created":363,"updated":364,"published":365},1776705362,1776710540,1776710541,{"seo":367,"og":370},{"title":368,"description":369},"Starting Statins as First-Line Therapy for Hyperlipidemia | Medmastery","Starting statins: how to choose the right agent for your patient, match statin intensity to cardiovascular risk, and monitor effectively after initiation.",{"title":368,"description":369,"image":371},{"alt":372,"title":307,"size":373,"location":376},"Healthcare provider discussing starting statins with a patient and reviewing a medication bottle",{"width":374,"height":375},900,473,{"bucket":311,"key":377},"\u002F2026-05\u002FC121(2)_Open graph_1200x630@0,75x.png",{"id":379,"created":380,"updated":381,"published":382},1351,1778960150,1778962081,1778961827]